Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

DePuy Reclaim Monobloc Revision Femoral Stem

K-Number: K221462 · 2022-10-21

Decision Date2022-10-21
Product CodeLZO
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

DePuy Reclaim Monobloc Revision Femoral Stem is a medical device manufactured by Depuy Ireland UC. It received FDA 510(k) clearance on 2022-10-21 under approval number K221462. The device is classified under product code LZO. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the DePuy Reclaim Monobloc Revision Femoral Stem?

DePuy Reclaim Monobloc Revision Femoral Stem is a medical device that received FDA 510(k) clearance on 2022-10-21. It is manufactured by Depuy Ireland UC. The 510(k) number is K221462.

When was DePuy Reclaim Monobloc Revision Femoral Stem approved by the FDA?

DePuy Reclaim Monobloc Revision Femoral Stem received FDA 510(k) clearance on 2022-10-21, under approval number K221462.

What company makes DePuy Reclaim Monobloc Revision Femoral Stem?

DePuy Reclaim Monobloc Revision Femoral Stem is manufactured by Depuy Ireland UC.

What is the FDA product code for DePuy Reclaim Monobloc Revision Femoral Stem?

The FDA product code for DePuy Reclaim Monobloc Revision Femoral Stem is LZO.

Related Clinical Trials

Other Devices by Depuy Ireland UC

View all 48 devices →

Related Devices (Code: LZO)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.